In addition, Hussain et al., (2007) showed that targeted down-regulation of Mcl-1 is enough to trigger apoptosis and enhance rituximab-mediated apoptosis in vitro in primary CLL cells. This evidence concerns the gene MCL1 and B-cell chronic lymphocytic leukemia.